Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Thursday, November 28, 2024 in observance of Thanksgiving. Have a healthy, happy holiday.

Hide

Innovations within Precision Oncology: Evolution of a Biomarker - a Case Study of KRAS-G12C

Innovations within Precision Oncology: Evolution of a Biomarker - a Case Study of KRAS-G12C

Quest Diagnostics Oncology Associate Medical Director Mark Kruzel, MD, MBA recently discussed the evolving biomarker landscape for non-small cell lung cancer (NSCLC) during the University of Miami Pathology Conference 2022.

 

Dr. Kruzel’s presentation, available on video, raises awareness of KRAS G12C as an actionable biomarker for NSCLC, and reviews available methods and clinical guidance recommendations for biomarker testing at the diagnosis of NSCLC. 

Date:
May 12, 2022
Location:
This webinar was first presented live (virtual) at the University of Miami Pathology Conference 2022, and was later posted as an on-demand webinar.
Presenter(s):
Mark Kruzel